一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> British Journal of Pharmacology >>article
British Journal of Pharmacology

British Journal of Pharmacology

IF: 6.8
Download PDF

PPARγ is a potential therapeutic target for radiation enteritis via suppressing ferroptosis, mediated by the GAPDH/glycosylation axis

Published:13 May 2025 DOI: 10.1111/bph.70045 PMID: 40361259
Xi Zeng, Liefeng Zhang, Hong Lu, Xinru Xue, Ling Yang, Xiuling Yang, Zhuohui Liu, Xiaoying Cao, Yue Dai, Zhifeng Wei

Abstract

Background and Purpose

Radiation enteritis (RE) is a severe complication after radiotherapy with no specific therapeutic agents. Here, we have attempted to identify the key therapeutic targets for RE, to advance drug development.

Experimental Approach

Therapeutic targets were screened and identified using RE patients' intestinal samples, bioinformatics, and mouse models. RNA sequencing, electron microscopy, metabolomics, glycolytic flux, co-immunoprecipitation, molecular docking, point mutation were used to identify mechanisms.

Key Results

Analysis of gene changes in response to ionising radiation showed extensive regulation of several differentially expressed genes by PPARγ, as well as its deficiency in activation and expression in RE. Both activation and overexpression of PPARγ significantly antagonised RE in vivo. Mechanistically, PPARγ specifically limited ferroptosis in intestinal epithelial cells exposed to ionising radiation, and its selective activation was more effective than full activation because of the reduced effect on the ferroptosis-driving genes PTEN and SAT1. Furthermore, ionising radiation caused the greatest changes in glucose metabolism. PPARγ targeted GAPDH at Lys107 to shift glycolysis to the hexosamine biosynthesis pathway, thereby enhancing glycosylation. In ionising radiation-induced ferroptosis, O/N-GlcNAcylation initially played antagonistic roles and later mediated the process, and they assisted PPARγ in restraining lysosomal degradation of heavy-chain ferritin (FTH1) and the transferrin receptor TFRC, thus controlling storage and transport of iron, and consequently alleviated ferroptosis.

Conclusion and Implications

PPARγ is a potential therapeutic target for RE, as it elicits GAPDH-mediated glucose metabolic reprogramming and alleviates ionising radiation-induced ferroptosis, in a glycosylation-dependent manner.

Substances (20)

Materials
Procduct Name CAS Molecular Formula Supplier Price
Rosiglitazone 122320-73-4 C18H19N3O3S 556 suppliers $8.00-$970.00
Rosiglitazone 122320-73-4 C18H19N3O3S 556 suppliers $8.00-$970.00
Rosiglitazone 122320-73-4 C18H19N3O3S 556 suppliers $8.00-$970.00
Rosiglitazone 122320-73-4 C18H19N3O3S 556 suppliers $8.00-$970.00
2-[1-[4-[2-(4-Chlorophenoxy)acetyl]-1-piperazinyl]ethyl]-3-(2-ethoxyphenyl)-4(3H)-Quinazolinone 571203-78-6 C30H31ClN4O4 284 suppliers $16.00-$2691.10
2-[1-[4-[2-(4-Chlorophenoxy)acetyl]-1-piperazinyl]ethyl]-3-(2-ethoxyphenyl)-4(3H)-Quinazolinone 571203-78-6 C30H31ClN4O4 284 suppliers $16.00-$2691.10
2-[1-[4-[2-(4-Chlorophenoxy)acetyl]-1-piperazinyl]ethyl]-3-(2-ethoxyphenyl)-4(3H)-Quinazolinone 571203-78-6 C30H31ClN4O4 284 suppliers $16.00-$2691.10
2-[1-[4-[2-(4-Chlorophenoxy)acetyl]-1-piperazinyl]ethyl]-3-(2-ethoxyphenyl)-4(3H)-Quinazolinone 571203-78-6 C30H31ClN4O4 284 suppliers $16.00-$2691.10
RSL3 1219810-16-8 C23H21ClN2O5 218 suppliers $13.00-$1872.00
RSL3 1219810-16-8 C23H21ClN2O5 218 suppliers $13.00-$1872.00
吕梁市| 揭东县| 吐鲁番市| 景泰县| 南丹县| 镇沅| 绵竹市| 新田县| 鹤山市| 隆德县| 中阳县| 武强县| 黄山市| 咸宁市| 绥棱县| 精河县| 昌江| 阿尔山市| 霍城县| 扶绥县| 明水县| 河北省| 江川县| 叙永县| 托克托县| 射洪县| 禹城市| 蓬莱市| 习水县| 公安县| 盘锦市| 永州市| 孟州市| 永嘉县| 吕梁市| 黔西县| 阜宁县| 万荣县| 陇西县| 齐河县| 石屏县|